nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—ankylosing spondylitis—systemic scleroderma	0.339	0.526	CtDrD
Sulfasalazine—rheumatoid arthritis—systemic scleroderma	0.306	0.474	CtDrD
Sulfasalazine—SLC46A1—Methotrexate—systemic scleroderma	0.0984	0.38	CbGbCtD
Sulfasalazine—ABCG2—Leflunomide—systemic scleroderma	0.0377	0.146	CbGbCtD
Sulfasalazine—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.0293	0.113	CbGbCtD
Sulfasalazine—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.0257	0.0995	CbGbCtD
Sulfasalazine—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.0233	0.09	CbGbCtD
Sulfasalazine—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0129	0.0498	CbGbCtD
Sulfasalazine—SLCO1B1—Methotrexate—systemic scleroderma	0.0117	0.0454	CbGbCtD
Sulfasalazine—ABCC2—Methotrexate—systemic scleroderma	0.0103	0.0399	CbGbCtD
Sulfasalazine—ABCG2—Methotrexate—systemic scleroderma	0.00933	0.0361	CbGbCtD
Sulfasalazine—SLC7A11—forelimb zeugopod—systemic scleroderma	0.00773	0.137	CbGeAlD
Sulfasalazine—TBXAS1—skeletal joint—systemic scleroderma	0.00698	0.124	CbGeAlD
Sulfasalazine—PPARG—dermis—systemic scleroderma	0.00305	0.0542	CbGeAlD
Sulfasalazine—PLA2G1B—blood vessel—systemic scleroderma	0.00191	0.0339	CbGeAlD
Sulfasalazine—ACAT1—connective tissue—systemic scleroderma	0.0014	0.0248	CbGeAlD
Sulfasalazine—PTGS2—skeletal joint—systemic scleroderma	0.00134	0.0239	CbGeAlD
Sulfasalazine—ACAT1—smooth muscle tissue—systemic scleroderma	0.00128	0.0227	CbGeAlD
Sulfasalazine—TBXAS1—connective tissue—systemic scleroderma	0.00117	0.0207	CbGeAlD
Sulfasalazine—PPARG—artery—systemic scleroderma	0.0011	0.0196	CbGeAlD
Sulfasalazine—TBXAS1—smooth muscle tissue—systemic scleroderma	0.00107	0.019	CbGeAlD
Sulfasalazine—CHUK—connective tissue—systemic scleroderma	0.00104	0.0185	CbGeAlD
Sulfasalazine—ACAT1—digestive system—systemic scleroderma	0.00101	0.0179	CbGeAlD
Sulfasalazine—PLA2G1B—connective tissue—systemic scleroderma	0.000978	0.0174	CbGeAlD
Sulfasalazine—ACAT1—tendon—systemic scleroderma	0.000959	0.0171	CbGeAlD
Sulfasalazine—CHUK—skin of body—systemic scleroderma	0.000939	0.0167	CbGeAlD
Sulfasalazine—PPARG—endothelium—systemic scleroderma	0.00093	0.0165	CbGeAlD
Sulfasalazine—PPARG—blood vessel—systemic scleroderma	0.000858	0.0152	CbGeAlD
Sulfasalazine—ACAT1—lung—systemic scleroderma	0.000842	0.015	CbGeAlD
Sulfasalazine—TBXAS1—tendon—systemic scleroderma	0.000802	0.0143	CbGeAlD
Sulfasalazine—SLC7A11—smooth muscle tissue—systemic scleroderma	0.000783	0.0139	CbGeAlD
Sulfasalazine—SLC46A1—digestive system—systemic scleroderma	0.000751	0.0133	CbGeAlD
Sulfasalazine—CHUK—digestive system—systemic scleroderma	0.000751	0.0133	CbGeAlD
Sulfasalazine—SLC46A1—tendon—systemic scleroderma	0.000715	0.0127	CbGeAlD
Sulfasalazine—IKBKB—connective tissue—systemic scleroderma	0.000707	0.0126	CbGeAlD
Sulfasalazine—PLA2G1B—digestive system—systemic scleroderma	0.000706	0.0126	CbGeAlD
Sulfasalazine—TBXAS1—lung—systemic scleroderma	0.000704	0.0125	CbGeAlD
Sulfasalazine—IKBKB—smooth muscle tissue—systemic scleroderma	0.000647	0.0115	CbGeAlD
Sulfasalazine—IKBKB—skin of body—systemic scleroderma	0.000638	0.0113	CbGeAlD
Sulfasalazine—CHUK—lung—systemic scleroderma	0.000627	0.0111	CbGeAlD
Sulfasalazine—SLC7A11—digestive system—systemic scleroderma	0.000618	0.011	CbGeAlD
Sulfasalazine—PLA2G1B—lung—systemic scleroderma	0.00059	0.0105	CbGeAlD
Sulfasalazine—PTGS1—artery—systemic scleroderma	0.000589	0.0105	CbGeAlD
Sulfasalazine—ALOX5—connective tissue—systemic scleroderma	0.000586	0.0104	CbGeAlD
Sulfasalazine—PTGS2—artery—systemic scleroderma	0.000563	0.01	CbGeAlD
Sulfasalazine—ALOX5—smooth muscle tissue—systemic scleroderma	0.000536	0.00953	CbGeAlD
Sulfasalazine—SLC7A11—lung—systemic scleroderma	0.000517	0.00918	CbGeAlD
Sulfasalazine—IKBKB—digestive system—systemic scleroderma	0.000511	0.00907	CbGeAlD
Sulfasalazine—PTGS1—endothelium—systemic scleroderma	0.000497	0.00884	CbGeAlD
Sulfasalazine—IKBKB—tendon—systemic scleroderma	0.000486	0.00864	CbGeAlD
Sulfasalazine—PTGS2—endothelium—systemic scleroderma	0.000475	0.00845	CbGeAlD
Sulfasalazine—PTGS1—blood vessel—systemic scleroderma	0.000459	0.00815	CbGeAlD
Sulfasalazine—PPARG—connective tissue—systemic scleroderma	0.00044	0.00782	CbGeAlD
Sulfasalazine—PTGS2—blood vessel—systemic scleroderma	0.000438	0.00779	CbGeAlD
Sulfasalazine—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.000436	0.244	CbGdCrCtD
Sulfasalazine—IKBKB—lung—systemic scleroderma	0.000426	0.00758	CbGeAlD
Sulfasalazine—ALOX5—digestive system—systemic scleroderma	0.000423	0.00752	CbGeAlD
Sulfasalazine—PPARG—smooth muscle tissue—systemic scleroderma	0.000402	0.00715	CbGeAlD
Sulfasalazine—PPARG—skin of body—systemic scleroderma	0.000397	0.00706	CbGeAlD
Sulfasalazine—SLCO1B1—digestive system—systemic scleroderma	0.000368	0.00655	CbGeAlD
Sulfasalazine—ALOX5—lung—systemic scleroderma	0.000353	0.00628	CbGeAlD
Sulfasalazine—SLC7A11—Betamethasone—Mometasone—systemic scleroderma	0.000352	0.197	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Mometasone—systemic scleroderma	0.000352	0.197	CbGdCrCtD
Sulfasalazine—PPARG—digestive system—systemic scleroderma	0.000318	0.00565	CbGeAlD
Sulfasalazine—PPARG—tendon—systemic scleroderma	0.000302	0.00537	CbGeAlD
Sulfasalazine—ABCC2—digestive system—systemic scleroderma	0.000279	0.00496	CbGeAlD
Sulfasalazine—ABCC2—tendon—systemic scleroderma	0.000266	0.00472	CbGeAlD
Sulfasalazine—PPARG—lung—systemic scleroderma	0.000265	0.00472	CbGeAlD
Sulfasalazine—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.000263	0.147	CbGdCrCtD
Sulfasalazine—PTGS1—connective tissue—systemic scleroderma	0.000235	0.00418	CbGeAlD
Sulfasalazine—PTGS2—connective tissue—systemic scleroderma	0.000225	0.00399	CbGeAlD
Sulfasalazine—PTGS1—smooth muscle tissue—systemic scleroderma	0.000215	0.00382	CbGeAlD
Sulfasalazine—PTGS1—skin of body—systemic scleroderma	0.000212	0.00377	CbGeAlD
Sulfasalazine—PTGS2—smooth muscle tissue—systemic scleroderma	0.000206	0.00365	CbGeAlD
Sulfasalazine—PTGS2—skin of body—systemic scleroderma	0.000203	0.00361	CbGeAlD
Sulfasalazine—SLC7A11—Dexamethasone—Prednisone—systemic scleroderma	0.000192	0.107	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Prednisone—systemic scleroderma	0.000192	0.107	CbGdCrCtD
Sulfasalazine—CYP3A5—digestive system—systemic scleroderma	0.000189	0.00336	CbGeAlD
Sulfasalazine—ABCG2—lung—systemic scleroderma	0.00017	0.00302	CbGeAlD
Sulfasalazine—PTGS1—digestive system—systemic scleroderma	0.00017	0.00302	CbGeAlD
Sulfasalazine—PTGS2—digestive system—systemic scleroderma	0.000162	0.00289	CbGeAlD
Sulfasalazine—PTGS1—tendon—systemic scleroderma	0.000162	0.00287	CbGeAlD
Sulfasalazine—CYP3A5—lung—systemic scleroderma	0.000158	0.00281	CbGeAlD
Sulfasalazine—PTGS2—tendon—systemic scleroderma	0.000154	0.00275	CbGeAlD
Sulfasalazine—IKBKB—B Cell Receptor Signaling Pathway—BLK—systemic scleroderma	0.000152	0.00401	CbGpPWpGaD
Sulfasalazine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—ITGAM—systemic scleroderma	0.000151	0.00398	CbGpPWpGaD
Sulfasalazine—PPARG—PPARA activates gene expression—CTGF—systemic scleroderma	0.000146	0.00384	CbGpPWpGaD
Sulfasalazine—IKBKB—GMCSF-mediated signaling events—CCL2—systemic scleroderma	0.000145	0.00382	CbGpPWpGaD
Sulfasalazine—CHUK—TWEAK Signaling Pathway—CCL2—systemic scleroderma	0.000145	0.0038	CbGpPWpGaD
Sulfasalazine—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—systemic scleroderma	0.000143	0.00376	CbGpPWpGaD
Sulfasalazine—CHUK—Regulation of toll-like receptor signaling pathway—IRF5—systemic scleroderma	0.000143	0.00375	CbGpPWpGaD
Sulfasalazine—PTGS1—lung—systemic scleroderma	0.000142	0.00252	CbGeAlD
Sulfasalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic scleroderma	0.000139	0.00364	CbGpPWpGaD
Sulfasalazine—ALOX5—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.000138	0.00362	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—ITGAM—systemic scleroderma	0.000137	0.00361	CbGpPWpGaD
Sulfasalazine—PTGS2—lung—systemic scleroderma	0.000136	0.00241	CbGeAlD
Sulfasalazine—CHUK—Toll-Like Receptors Cascades—ITGAM—systemic scleroderma	0.000135	0.00354	CbGpPWpGaD
Sulfasalazine—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic scleroderma	0.000133	0.0035	CbGpPWpGaD
Sulfasalazine—PTGS2—C-MYB transcription factor network—COL1A2—systemic scleroderma	0.000133	0.0035	CbGpPWpGaD
Sulfasalazine—CHUK—Osteopontin-mediated events—MMP9—systemic scleroderma	0.000132	0.00347	CbGpPWpGaD
Sulfasalazine—IKBKB—TWEAK Signaling Pathway—CCL2—systemic scleroderma	0.000131	0.00345	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—SELP—systemic scleroderma	0.00013	0.00342	CbGpPWpGaD
Sulfasalazine—CHUK—IL1-mediated signaling events—IL1B—systemic scleroderma	0.00013	0.00342	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—IRF5—systemic scleroderma	0.000129	0.0034	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TNFSF13—systemic scleroderma	0.000129	0.00339	CbGpPWpGaD
Sulfasalazine—CHUK—Regulation of toll-like receptor signaling pathway—TNFAIP3—systemic scleroderma	0.000128	0.00335	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.000123	0.00322	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-Like Receptors Cascades—ITGAM—systemic scleroderma	0.000122	0.00321	CbGpPWpGaD
Sulfasalazine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—EDN1—systemic scleroderma	0.000122	0.0032	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—RHOB—systemic scleroderma	0.000121	0.00319	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—CSK—systemic scleroderma	0.000118	0.00311	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.000118	0.0031	CbGpPWpGaD
Sulfasalazine—IKBKB—IL1-mediated signaling events—IL1B—systemic scleroderma	0.000118	0.0031	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—CSK—systemic scleroderma	0.000117	0.00308	CbGpPWpGaD
Sulfasalazine—CHUK—IL-1 signaling pathway—CCL2—systemic scleroderma	0.000117	0.00307	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—TNFAIP3—systemic scleroderma	0.000116	0.00304	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—SELP—systemic scleroderma	0.000115	0.00303	CbGpPWpGaD
Sulfasalazine—ABCG2—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	0.000115	0.00301	CbGpPWpGaD
Sulfasalazine—CHUK—TCR Signaling Pathway—IL1A—systemic scleroderma	0.000114	0.00301	CbGpPWpGaD
Sulfasalazine—CHUK—Interleukin-1 signaling—IL1B—systemic scleroderma	0.000114	0.003	CbGpPWpGaD
Sulfasalazine—CHUK—NOD pathway—IL1B—systemic scleroderma	0.000112	0.00294	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—CSK—systemic scleroderma	0.000111	0.00291	CbGpPWpGaD
Sulfasalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—EDN1—systemic scleroderma	0.00011	0.0029	CbGpPWpGaD
Sulfasalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic scleroderma	0.000108	0.00283	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—RHOB—systemic scleroderma	0.000107	0.00282	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.000106	0.00279	CbGpPWpGaD
Sulfasalazine—IKBKB—IL-1 signaling pathway—CCL2—systemic scleroderma	0.000106	0.00278	CbGpPWpGaD
Sulfasalazine—ALOX5—Selenium Micronutrient Network—IL1B—systemic scleroderma	0.000105	0.00275	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—ITGAM—systemic scleroderma	0.000104	0.00273	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR Signaling Pathway—IL1A—systemic scleroderma	0.000104	0.00273	CbGpPWpGaD
Sulfasalazine—CHUK—TWEAK Signaling Pathway—MMP9—systemic scleroderma	0.000103	0.00272	CbGpPWpGaD
Sulfasalazine—IKBKB—Interleukin-1 signaling—IL1B—systemic scleroderma	0.000103	0.00272	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—SMAD7—systemic scleroderma	0.000103	0.00271	CbGpPWpGaD
Sulfasalazine—IKBKB—NOD pathway—IL1B—systemic scleroderma	0.000101	0.00267	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by Interleukins—IL1A—systemic scleroderma	9.89e-05	0.0026	CbGpPWpGaD
Sulfasalazine—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—systemic scleroderma	9.85e-05	0.00259	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—BLK—systemic scleroderma	9.62e-05	0.00253	CbGpPWpGaD
Sulfasalazine—CHUK—AGE/RAGE pathway—MMP2—systemic scleroderma	9.59e-05	0.00252	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—HSPG2—systemic scleroderma	9.5e-05	0.0025	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—TGFBI—systemic scleroderma	9.43e-05	0.00248	CbGpPWpGaD
Sulfasalazine—IKBKB—TWEAK Signaling Pathway—MMP9—systemic scleroderma	9.38e-05	0.00247	CbGpPWpGaD
Sulfasalazine—CHUK—AGE/RAGE pathway—NOS3—systemic scleroderma	8.98e-05	0.00236	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by Interleukins—IL1A—systemic scleroderma	8.96e-05	0.00236	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	8.94e-05	0.00235	CbGpPWpGaD
Sulfasalazine—CHUK—IL-1 signaling pathway—IL1B—systemic scleroderma	8.85e-05	0.00232	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—BLK—systemic scleroderma	8.72e-05	0.00229	CbGpPWpGaD
Sulfasalazine—IKBKB—AGE/RAGE pathway—MMP2—systemic scleroderma	8.7e-05	0.00229	CbGpPWpGaD
Sulfasalazine—PPARG—Generic Transcription Pathway—SMAD7—systemic scleroderma	8.44e-05	0.00222	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	8.36e-05	0.0022	CbGpPWpGaD
Sulfasalazine—CHUK—Interleukin-11 Signaling Pathway—TGFB1—systemic scleroderma	8.22e-05	0.00216	CbGpPWpGaD
Sulfasalazine—IKBKB—AGE/RAGE pathway—NOS3—systemic scleroderma	8.15e-05	0.00214	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—IRF5—systemic scleroderma	8.14e-05	0.00214	CbGpPWpGaD
Sulfasalazine—CHUK—Leptin signaling pathway—NOS3—systemic scleroderma	8.11e-05	0.00213	CbGpPWpGaD
Sulfasalazine—IKBKB—IL-1 signaling pathway—IL1B—systemic scleroderma	8.02e-05	0.00211	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—IRF8—systemic scleroderma	7.78e-05	0.00205	CbGpPWpGaD
Sulfasalazine—CHUK—TNF alpha Signaling Pathway—CCL2—systemic scleroderma	7.73e-05	0.00203	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—HSPG2—systemic scleroderma	7.52e-05	0.00198	CbGpPWpGaD
Sulfasalazine—IKBKB—Interleukin-11 Signaling Pathway—TGFB1—systemic scleroderma	7.45e-05	0.00196	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IRF5—systemic scleroderma	7.38e-05	0.00194	CbGpPWpGaD
Sulfasalazine—IKBKB—Leptin signaling pathway—NOS3—systemic scleroderma	7.35e-05	0.00193	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—CSK—systemic scleroderma	7.26e-05	0.00191	CbGpPWpGaD
Sulfasalazine—CHUK—AGE/RAGE pathway—MMP9—systemic scleroderma	7.21e-05	0.00189	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—CTGF—systemic scleroderma	7.2e-05	0.00189	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—HSPG2—systemic scleroderma	7.2e-05	0.00189	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IRF8—systemic scleroderma	7.06e-05	0.00185	CbGpPWpGaD
Sulfasalazine—IKBKB—TNF alpha Signaling Pathway—CCL2—systemic scleroderma	7.01e-05	0.00184	CbGpPWpGaD
Sulfasalazine—CHUK—Leptin signaling pathway—IL1B—systemic scleroderma	6.9e-05	0.00181	CbGpPWpGaD
Sulfasalazine—CHUK—Cardiac Hypertrophic Response—TGFB1—systemic scleroderma	6.87e-05	0.00181	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—CD247—systemic scleroderma	6.83e-05	0.00179	CbGpPWpGaD
Sulfasalazine—SLC7A11—NRF2 pathway—TGFB1—systemic scleroderma	6.75e-05	0.00177	CbGpPWpGaD
Sulfasalazine—IKBKB—AGE/RAGE pathway—MMP9—systemic scleroderma	6.54e-05	0.00172	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—MMP1—systemic scleroderma	6.39e-05	0.00168	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	6.34e-05	0.00167	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—HSPG2—systemic scleroderma	6.3e-05	0.00165	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—IL1A—systemic scleroderma	6.3e-05	0.00165	CbGpPWpGaD
Sulfasalazine—IKBKB—Leptin signaling pathway—IL1B—systemic scleroderma	6.26e-05	0.00164	CbGpPWpGaD
Sulfasalazine—IKBKB—Cardiac Hypertrophic Response—TGFB1—systemic scleroderma	6.23e-05	0.00164	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—RHOB—systemic scleroderma	6.15e-05	0.00162	CbGpPWpGaD
Sulfasalazine—PTGS1—Selenium Micronutrient Network—CCL2—systemic scleroderma	5.98e-05	0.00157	CbGpPWpGaD
Sulfasalazine—CHUK—TCR Signaling Pathway—IL1B—systemic scleroderma	5.97e-05	0.00157	CbGpPWpGaD
Sulfasalazine—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—systemic scleroderma	5.59e-05	0.00147	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—CTGF—systemic scleroderma	5.46e-05	0.00143	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—IL1A—systemic scleroderma	5.46e-05	0.00143	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR Signaling Pathway—IL1B—systemic scleroderma	5.41e-05	0.00142	CbGpPWpGaD
Sulfasalazine—CHUK—Toll-like Receptor Signaling Pathway—IL1B—systemic scleroderma	5.4e-05	0.00142	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—HSPG2—systemic scleroderma	5.25e-05	0.00138	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—MMP1—systemic scleroderma	5.21e-05	0.00137	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	5.18e-05	0.00136	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by Interleukins—IL1B—systemic scleroderma	5.16e-05	0.00136	CbGpPWpGaD
Sulfasalazine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—systemic scleroderma	4.9e-05	0.00129	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-like Receptor Signaling Pathway—IL1B—systemic scleroderma	4.89e-05	0.00129	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—HLA-DQB1—systemic scleroderma	4.86e-05	0.00128	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—CTGF—systemic scleroderma	4.77e-05	0.00125	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—CCL2—systemic scleroderma	4.74e-05	0.00125	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by Interleukins—IL1B—systemic scleroderma	4.67e-05	0.00123	CbGpPWpGaD
Sulfasalazine—PPARG—Generic Transcription Pathway—CTGF—systemic scleroderma	4.67e-05	0.00123	CbGpPWpGaD
Sulfasalazine—CHUK—TCR Signaling Pathway—TGFB1—systemic scleroderma	4.64e-05	0.00122	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—IL1A—systemic scleroderma	4.61e-05	0.00121	CbGpPWpGaD
Sulfasalazine—PTGS1—Selenium Micronutrient Network—IL1B—systemic scleroderma	4.53e-05	0.00119	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CSK—systemic scleroderma	4.46e-05	0.00117	CbGpPWpGaD
Sulfasalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—systemic scleroderma	4.44e-05	0.00117	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—HLA-DQB1—systemic scleroderma	4.4e-05	0.00116	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CD247—systemic scleroderma	4.36e-05	0.00115	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—ITGAM—systemic scleroderma	4.36e-05	0.00115	CbGpPWpGaD
Sulfasalazine—CHUK—Regulation of toll-like receptor signaling pathway—IL1B—systemic scleroderma	4.21e-05	0.00111	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR Signaling Pathway—TGFB1—systemic scleroderma	4.2e-05	0.0011	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD247—systemic scleroderma	4.19e-05	0.0011	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IL1A—systemic scleroderma	4.18e-05	0.0011	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—TNFAIP3—systemic scleroderma	4.09e-05	0.00107	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	4.08e-05	0.00107	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—SMAD7—systemic scleroderma	4.06e-05	0.00107	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CSK—systemic scleroderma	4.04e-05	0.00106	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—CTGF—systemic scleroderma	3.98e-05	0.00105	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CD247—systemic scleroderma	3.96e-05	0.00104	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—ITGAM—systemic scleroderma	3.96e-05	0.00104	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by SCF-KIT—MMP9—systemic scleroderma	3.93e-05	0.00103	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	3.92e-05	0.00103	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—BLK—systemic scleroderma	3.88e-05	0.00102	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—IL1B—systemic scleroderma	3.82e-05	0.001	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD247—systemic scleroderma	3.8e-05	0.000999	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—TNFSF13—systemic scleroderma	3.78e-05	0.000993	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—NOS3—systemic scleroderma	3.78e-05	0.000993	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—CCL2—systemic scleroderma	3.75e-05	0.000986	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—HSPG2—systemic scleroderma	3.72e-05	0.000979	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—TNFAIP3—systemic scleroderma	3.71e-05	0.000974	CbGpPWpGaD
Sulfasalazine—PPARG—Adipogenesis—TGFB1—systemic scleroderma	3.68e-05	0.000967	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	3.63e-05	0.000953	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—IL1B—systemic scleroderma	3.6e-05	0.000946	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—SMAD7—systemic scleroderma	3.54e-05	0.000931	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—BLK—systemic scleroderma	3.52e-05	0.000924	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—IL1B—systemic scleroderma	3.28e-05	0.000863	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—TGFBI—systemic scleroderma	3.24e-05	0.000852	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CTLA4—systemic scleroderma	3.18e-05	0.000835	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—NOS3—systemic scleroderma	3.14e-05	0.000824	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	3.09e-05	0.000812	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CTLA4—systemic scleroderma	2.88e-05	0.000757	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	2.88e-05	0.000757	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—IL1B—systemic scleroderma	2.85e-05	0.000748	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—CTGF—systemic scleroderma	2.82e-05	0.000742	CbGpPWpGaD
Sulfasalazine—ABCC2—NRF2 pathway—TGFB1—systemic scleroderma	2.81e-05	0.000739	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2.75e-05	0.000722	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CSK—systemic scleroderma	2.7e-05	0.000711	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—MMP9—systemic scleroderma	2.68e-05	0.000705	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IRF5—systemic scleroderma	2.66e-05	0.000699	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—HLA-DQB1—systemic scleroderma	2.62e-05	0.000687	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—HSPG2—systemic scleroderma	2.58e-05	0.000679	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—TGFB1—systemic scleroderma	2.55e-05	0.000671	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IRF8—systemic scleroderma	2.54e-05	0.000668	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD247—systemic scleroderma	2.54e-05	0.000668	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—ITGAM—systemic scleroderma	2.54e-05	0.000668	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	2.54e-05	0.000667	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—TGFB1—systemic scleroderma	2.5e-05	0.000656	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CSK—systemic scleroderma	2.5e-05	0.000656	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SMAD7—systemic scleroderma	2.48e-05	0.000652	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—NOS3—systemic scleroderma	2.48e-05	0.000652	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD40LG—systemic scleroderma	2.47e-05	0.000649	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CSK—systemic scleroderma	2.45e-05	0.000644	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IRF5—systemic scleroderma	2.41e-05	0.000634	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—IL1B—systemic scleroderma	2.41e-05	0.000632	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—TNFAIP3—systemic scleroderma	2.38e-05	0.000626	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—NOS3—systemic scleroderma	2.38e-05	0.000625	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HLA-DQB1—systemic scleroderma	2.37e-05	0.000623	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—BLK—systemic scleroderma	2.35e-05	0.000618	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CD247—systemic scleroderma	2.35e-05	0.000617	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—HSPG2—systemic scleroderma	2.31e-05	0.000606	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—ITGAM—systemic scleroderma	2.31e-05	0.000606	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IRF8—systemic scleroderma	2.31e-05	0.000606	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD247—systemic scleroderma	2.31e-05	0.000606	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SMAD7—systemic scleroderma	2.25e-05	0.000591	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—CTGF—systemic scleroderma	2.25e-05	0.000591	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD40LG—systemic scleroderma	2.24e-05	0.000589	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TGFB1—systemic scleroderma	2.21e-05	0.000581	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2.18e-05	0.000574	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IL1B—systemic scleroderma	2.18e-05	0.000573	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—TNFAIP3—systemic scleroderma	2.16e-05	0.000567	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—BLK—systemic scleroderma	2.13e-05	0.000561	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—SMAD7—systemic scleroderma	2.1e-05	0.000552	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—NOS3—systemic scleroderma	2.08e-05	0.000546	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—MMP2—systemic scleroderma	2.04e-05	0.000537	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CTLA4—systemic scleroderma	1.93e-05	0.000506	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TGFBI—systemic scleroderma	1.92e-05	0.000505	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—RHOB—systemic scleroderma	1.92e-05	0.000504	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—HSPG2—systemic scleroderma	1.82e-05	0.000477	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HSPG2—systemic scleroderma	1.81e-05	0.000476	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CSK—systemic scleroderma	1.75e-05	0.000459	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—CTGF—systemic scleroderma	1.75e-05	0.000459	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CTLA4—systemic scleroderma	1.75e-05	0.000459	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—RHOB—systemic scleroderma	1.74e-05	0.000457	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—NOS3—systemic scleroderma	1.73e-05	0.000456	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—HSPG2—systemic scleroderma	1.68e-05	0.000442	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HSPG2—systemic scleroderma	1.64e-05	0.000431	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—TGFB1—systemic scleroderma	1.64e-05	0.000431	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—HSPG2—systemic scleroderma	1.62e-05	0.000425	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-DQB1—systemic scleroderma	1.59e-05	0.000417	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CSK—systemic scleroderma	1.59e-05	0.000417	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—MMP9—systemic scleroderma	1.53e-05	0.000403	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HSPG2—systemic scleroderma	1.53e-05	0.000402	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL1A—systemic scleroderma	1.51e-05	0.000396	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	1.5e-05	0.000395	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD40LG—systemic scleroderma	1.5e-05	0.000394	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CSK—systemic scleroderma	1.48e-05	0.000389	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-DQB1—systemic scleroderma	1.44e-05	0.000378	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CD247—systemic scleroderma	1.39e-05	0.000365	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CTGF—systemic scleroderma	1.38e-05	0.000362	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL1A—systemic scleroderma	1.37e-05	0.000359	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD40LG—systemic scleroderma	1.36e-05	0.000357	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—HSPG2—systemic scleroderma	1.28e-05	0.000337	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CTGF—systemic scleroderma	1.27e-05	0.000335	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—TGFB1—systemic scleroderma	1.26e-05	0.000332	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—NOS3—systemic scleroderma	1.23e-05	0.000323	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CTGF—systemic scleroderma	1.22e-05	0.000322	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—HSPG2—systemic scleroderma	1.2e-05	0.000317	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—EDN1—systemic scleroderma	9.8e-06	0.000258	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CTGF—systemic scleroderma	9.72e-06	0.000255	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CTGF—systemic scleroderma	9.13e-06	0.00024	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EDN1—systemic scleroderma	8.89e-06	0.000234	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NOS3—systemic scleroderma	8.53e-06	0.000224	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL1B—systemic scleroderma	7.86e-06	0.000207	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—NOS3—systemic scleroderma	7.61e-06	0.0002	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL1B—systemic scleroderma	7.13e-06	0.000187	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCL2—systemic scleroderma	6.7e-06	0.000176	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCL2—systemic scleroderma	6.07e-06	0.00016	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—NOS3—systemic scleroderma	5.99e-06	0.000157	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NOS3—systemic scleroderma	5.97e-06	0.000157	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—TGFB1—systemic scleroderma	5.64e-06	0.000148	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—NOS3—systemic scleroderma	5.55e-06	0.000146	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NOS3—systemic scleroderma	5.41e-06	0.000142	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—NOS3—systemic scleroderma	5.33e-06	0.00014	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOS3—systemic scleroderma	5.05e-06	0.000133	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MMP9—systemic scleroderma	4.79e-06	0.000126	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MMP9—systemic scleroderma	4.34e-06	0.000114	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—NOS3—systemic scleroderma	4.23e-06	0.000111	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—NOS3—systemic scleroderma	3.97e-06	0.000104	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TGFB1—systemic scleroderma	3.95e-06	0.000104	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TGFB1—systemic scleroderma	3.58e-06	9.41e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TGFB1—systemic scleroderma	3.34e-06	8.78e-05	CbGpPWpGaD
